Cloaking Informed Consent in Clinical Trials: A California Stem Cell Case
Patients come first. That’s the rhetoric from biotech companies and agencies like the FDA, which has oversight responsibilities for clinical trials.
But when it comes down to specifics, the doors may close and little revealed publicly.
The case in point involves StemCells, Inc., which was charged last week in a lawsuit with endangering patients involved i…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.